Christopher Moore Joins Hogan Lovells’ Global M&A Practice
Hogan Lovells announced that Christopher Moore has joined the firm’s Corporate Practice as a partner in Northern California.
“Chris is a tremendous addition to our global M&A team, with deep expertise advising clients on both public and private transactions,” said David Gibbons, Global Head of Hogan Lovells’ Corporate Practice Group. “His joining is another step in our focused effort to increase the capabilities of our M&A practice in key markets.”
Moore joins from Weil, Gotshal & Manges on the heels of the addition of market-leading M&A partners Richard Climan, Keith Flaum, Jane Ross and IP and Technology Transactions partner John Brockland, all of whom Moore worked with extensively at his prior firm.
“Chris is a superb M&A lawyer. Our clients very much enjoyed working with him at our prior firm, and we are elated that he has decided to join us at Hogan Lovells,” said Climan.
Moore focuses on representing major technology and life sciences companies on a wide range of domestic and cross-border transactional matters, including acquisitions, divestitures, and joint ventures. He has played a leading role on teams advising Eli Lilly on its acquisition of CoLucid Pharmaceuticals; zulily on its sale to Liberty Interactive; XenoPort on its sale to Arbor Pharmaceuticals; Adobe Systems on its acquisition of Aviary; Synopsys on its acquisitions of Protecode, Gold Standard Simulations, Cigital and Codiscope; and Vonage on its acquisitions of Telesphere Networks, Simple Signal and iCore Networks.
“I’m excited to again team up with Rick, Keith, and Jane as part of the top-ranked Hogan Lovells corporate team,” said Moore. “Hogan Lovells’ platform and market leading expertise in key areas will help us continue to deliver top-tier M&A services to clients across the globe.”
Moore received a B.A. cum laude and a J.D. from the University of California Los Angeles.
